Literature DB >> 11279191

Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity.

K Nickerson1, T J Sisk, N Inohara, C S Yee, J Kennell, M C Cho, P J Yannie, G Nunez, C H Chang.   

Abstract

The MHC class II transactivator (CIITA) is a critical transcription factor that regulates genes involved in antigen presentation function. At least three functional forms of CIITA gene products are transcribed from three different promoters. The CIITA gene expressed in dendritic cells (DC-CIITA) has a unique first exon encoding an extended N-terminal region of CIITA. Here, we show that the N terminus of DC-CIITA has high homology to a caspase recruitment domain (CARD) found in components of apoptosis and nuclear factor-kappaB signaling pathways. However, DC-CIITA does not regulate cell death, nor does it induce nuclear factor-kappaB activity. Instead, DC-CIITA is transcriptionally a more potent activator of the MHC class II gene than the form expressed in B cells. A single amino acid substitution in the CARD of DC-CIITA, predicted to disrupt CARD-CARD interactions, diminished the transactivation potential of DC-CIITA. These results indicate that the CARD in the context of CIITA serves as a regulatory domain for transcriptional activity and may function to selectively enhance MHC class II gene expression in dendritic cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11279191     DOI: 10.1074/jbc.M101295200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Effector functions of NLRs in the intestine: innate sensing, cell death, and disease.

Authors:  Garabet Yeretssian
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

2.  Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells.

Authors:  Giovanna Butticè; Janice Miller; Lin Wang; Barbara D Smith
Journal:  Circ Res       Date:  2006-01-26       Impact factor: 17.367

Review 3.  The PYRIN domain in signal transduction.

Authors:  Christian Stehlik
Journal:  Curr Protein Pept Sci       Date:  2007-06       Impact factor: 3.272

Review 4.  NLR proteins: integral members of innate immunity and mediators of inflammatory diseases.

Authors:  Jeanette M Wilmanski; Tanja Petnicki-Ocwieja; Koichi S Kobayashi
Journal:  J Leukoc Biol       Date:  2007-09-17       Impact factor: 4.962

Review 5.  NOD-like receptor (NLR) signaling beyond the inflammasome.

Authors:  Patrick J Shaw; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

6.  A novel CARD containing splice-isoform of CIITA regulates nitric oxide synthesis in dendritic cells.

Authors:  Dachuan Huang; Sylvia Lim; Rong Yuan Ray Chua; Hong Shi; Mah Lee Ng; Siew Heng Wong
Journal:  Protein Cell       Date:  2010-04-17       Impact factor: 14.870

Review 7.  NLRC5: a newly discovered MHC class I transactivator (CITA).

Authors:  Torsten B Meissner; Amy Li; Koichi S Kobayashi
Journal:  Microbes Infect       Date:  2011-12-22       Impact factor: 2.700

Review 8.  Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.

Authors:  Saptha Vijayan; Tabasum Sidiq; Suhail Yousuf; Peter J van den Elsen; Koichi S Kobayashi
Journal:  Immunogenetics       Date:  2019-01-31       Impact factor: 2.846

9.  Elevated IL-6 expression in CD4 T cells via PKCtheta and NF-kappaB induces Th2 cytokine production.

Authors:  M Hanief Sofi; Wei Li; Mark H Kaplan; Cheong-Hee Chang
Journal:  Mol Immunol       Date:  2009-01-31       Impact factor: 4.407

10.  Comparative analysis of apoptosis and inflammation genes of mice and humans.

Authors:  John C Reed; Kutbuddin Doctor; Ana Rojas; Juan M Zapata; Christian Stehlik; Loredana Fiorentino; Jason Damiano; Wilfried Roth; Shu-Ichi Matsuzawa; Ruchi Newman; Shinichi Takayama; Hiroyuki Marusawa; Famming Xu; Guy Salvesen; Adam Godzik
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.